Special Letter from Dr. C. Lowe, LLC

[Guest guest]

From: Dr.

C. Lowe, LLC [mailto:drlowe@...] On Behalf Of Dr. C.

Lowe, LLC

Sent: 24 June 2010 22:13

amanda.jennings@...

Subject: Special Letter from Dr. C. Lowe, LLC

Having

trouble viewing this email? Click here.

Update Dr

C Lowe LLC

Metabolic

Research and Informational Consulting

June 24,

2010

www.drlowe.com Tammy@...

An Update

Letter from Dr. C. Lowe:

Thyro-Gold

More Potent than Expected

Dear Friends,

It is unusual to report the outcome of a study before

the official journal paper is published. However, we have

information that we believe is extremely important to those who use

Thyro-Gold or dispense it to their patients.

The information is that the product has a potency

higher than we expected. We initially heard this from people who

have used Thyro-Gold, and now we have confirmed it in two initial

formal studies. The two studies will soon be published, but we

believe the information is important enough to send out this letter

beforehand.

To make sure that Thyro-Gold is of the highest

quality, the manufacturer obtained the raw thyroid tissue from

New Zealand. You may have noticed that most companies that

market dietary desiccated thyroid products no longer

report New Zealand as the source of their raw material. From

what I've learned by being involved in all stages of making

Thyro-Gold available for customers, I've learned that most

companies have moved to countries other than New Zealand for

their raw material. The reason appears to be the relatively

high cost of obtaining New Zealand thyroid tissue. Franconia Ltd,

however, didn't let that be an obstacle to including New

Zealand bovine thyroid tissue in Thyro-Gold.

Initial Studies of Thyro-Gold.

As soon as Thyro-Gold was available, we promptly began

the studies of the product that we had planned. This initial

research has involved a type of study called a

" dose-response curve " investigation.

The particular dose-response format we used involves

intensely studying one person whom we call a " study

subject. " The subject serves as his or her own control. In

this type of study, championed by behavioral scientists, the

subject goes through several study phases. In each of the

phases, he or she takes a different product and undergoes

multiple comprehensive metabolic evaluations during each phase. The

point is to statistically compare the effects of each product

to the others in their respective study phases.

All new drugs are supposed to be evaluated by dose-response

curve investigations. Of course, Thyro-Gold is not a

drug. It's a whole-gland dietary desiccated thyroid product.

Nonetheless, our research orientation compelled us to subject the

product to dose-response testing.

Why We're Reporting the Higher-than-Expected

Potency Only Now. Some people who are using Thyro-Gold told us they

felt that the product is stronger than other products, such as HSF.

Feedback was mixed, however. Must people felt Thyro-Gold is

stronger, but others didn't feel that way.

The only way to learn which people

were right was to complete controlled studies involving

meaningful measurements. We've now completed the initial

two studies, and the evidence is clear enough. As

with most studies, however, some interpretation is needed on

some points. This is the case in the second study we'll soon

publish. We're now about to start a different type of

investigation involving a group of subjects. This

study will take a few months to complete.

But for those who are interested, I want

to briefly explain what was involved in conducting the two

studies we're about to report in Thyroid

Science. I have two reasons for giving the

explaination. First, I'd like for those who use

Thyro-Gold to appreciate that single-subject studies are

meaningful and have provided us with important information about

the product. And second, by understanding the enormous

time-investiment involved, I hope they'll understand why

it's taken until now to confirmation for them that Thyro-Gold

is more

potent that we had expected.

What was Involved in Our Initial Studies.

Single-subject dose-response studies are demanding,

laborious, and time-consuming. First, we had to repeatedly

measure a study subject's basal

metabolic rate, armpit temperature, pulse rate, and blood pressure.

The term " basal " means that we took the measurements with

the subject in as close to a vegetative state as possible.

Otherwise, the measurements wouldn't have been meaningful

and reliable. To get basal measurements, we had to

take measurements either in the middle of the subject's sleep

time, or immediately when he or she awoke and was in a groggy

state.

Shortly after the subject woke up and was

out of bed, we had to measure his or her body composition with

a research-quality bioelectrical impedance instrument. Afterward,

the subject fill out a series of evaluation forms.

Collecting the data for the subject's daily

evaluations, however, was just the beginning of the work. We then

had to score the subject's evaluation forms, and tabulate all the

collected data in a spreadsheet program. After all the data was

collected and tabulated, we spent days-on-end running various

statistical analyses from every possible mathematical direction.

The reason for the extensive data analyses was to learn

everything we could of what our study data potentially

revealed to us.

Last, we're preparing the manuscripts for

publications that will report the two studies. Today, we're pushing

to get the first study report to press, and we hope it will appear

in Thyroid

Science by the beginning of next week. If you

haven't signed up for a free subscription to Thyroid Science,

you can sign up with your email address at the homepage,

www.ThyroidScience.com. That way, you'll receive email notices when the

journal publishes the studies.

Our ultimate aim from these initial studies is to

learn the dosage equivalence of Thyro-Gold to other

products. It is the equivalences that will enable clinicians and

their patients, and those who self-treat, to most smoothly

transition from product-to-product. And the equivalences will

enable those who understand them to better select starting dosages.

Request for Feedback from Customers.

Aside from the studies I described above, we've

already learned a lot about Thyro-Gold from many people who have

used the product. They've kindly given us feedback on their

personal experiences with the product.

We're asking for feedback from anyone

who uses Thyro-Gold. We welcome it whether it's positive

or negative, and the more detail the better. We're accumulating

a data bank of information based on the feedback, and as soon

as possible, we'll make the information readily available.

We'll be immensely grateful to you if you'll help by

giving us feedback on your experiences.

Finally, we sincerely hope the benefits you get from

Thyro-Gold are highly satisfying to you, and we hope the

product helps you recover and optimize your health.

Equally important, though, we hope you'll use the product safely.

All best wishes to you,

Yours sincerely,

Dr. C. Lowe

Director of Research: Fibromyalgia Research Foundation

www.FibromyalgiaResearch.org

Editor-in-Chief: Thyroid Science

www.ThyroidScience.com

(603) 391-6061, www.drlowe.com

drlowe@...

Tammy@...

http://www.drlowe.com/jcl/biojcl.htm

The following webpage introduces

Thyro-Gold to those who aren't familiar with

it:

http://www.thyroidscience.us/products/thyro.gold/intro.thyro.gold.htm

Thyro-Gold comes from pasture-fed New Zealand

cows.

Forward email

This email was sent to amanda.jennings@... by drlowe@....

Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy.

Email

Marketing by

Dr. C. Lowe, LLC | 19

Long Springs Place | The Woodlands | TX | 77382

No virus

found in this incoming message.

Checked by AVG - www.avg.com

Version: 8.5.439 / Virus Database: 271.1.1/2959 - Release Date: 06/24/10

18:35:00